Velan Capital Investment Management »

Kazia Therapeutics shares owned by Velan Capital Investment Management

Quarter-by-quarter ownership of Kazia Therapeutics (KZIA) shares owned by Velan Capital Investment Management from 13F filings

Historical chart of Velan Capital Investment Management investment in Kazia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kazia Therapeutics held by Velan Capital Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kazia Therapeutics by Velan Capital Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.1M 300k 6.89

More positions owned by Velan Capital Investment Management

Praxis Precision Medicines I Com New (PRAX)
Cidara Therapeutics Com New (CDTX)
Protara Therapeutics Com Stk (TARA)
Heron Therapeutics (HRTX)
Maplight Therapeutics (MPLT)
Abivax Sa Sponsored Ads (ABVX)
Evommune Com Shs (EVMN)
Mineralys Therapeutics (MLYS)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Jasper Therapeutics Com New (JSPR)
Avalo Therapeutics Com New (AVTX)
Esperion Therapeutics (ESPR)
Verrica Pharmaceuticals Com Shs (VRCA)
Inspiremd (NSPR)
Rapt Therapeutics Com New (RAPT)

View all positions for Velan Capital Investment Management

Top funds holding Kazia Therapeutics

Alyeska Investment Group
Stonepine Capital Management
Bleichroeder
Velan Capital Investment Management
Point72 Asset Management
Empery Asset Management
Dauntless Investment Group
Westside Investment Management
Barclays
Rockefeller Capital Management
Engineers Gate Manager
FNY Investment Advisers
Rhumbline Advisers
GAMMA Investing
SRS Capital Advisors

View all funds holding Kazia Therapeutics